A synthetic approach to a novel class of enantiopure cyclopentyl carbocyclic nucleosides and related compounds

Tetrahedron Asymmetry

Volumn 8, Issue 20, 1997, Pages 3421-3430

  Díaz, Miguel ^a   Ortuño, Rosa M ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOCYCLIC NUCLEOSIDE;

ARTICLE; CHEMICAL STRUCTURE; CYCLIZATION; ENANTIOMER; PRIORITY JOURNAL; STEREOCHEMISTRY; SYNTHESIS;

EID: 0042087895     PISSN: 09574166     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0957-4166(97)00401-1     Document Type: Article

References (23)

1. Kusaka, T.; Yamamoto, H.; Shibata, M.; Muroi, M.; Kishi, T.; Mizuno, K. J. Antibiot. 1968, 21, 255.
2. Yaginuma, S.; Muto, N.; Tsujino, M.; Sudate, Y.; Hayashi, M.; Ohani, M. J. Antibiot. 1981, 34, 359.
3. For reviews on the synthesis and biological activity of carbocyclic nucleosides, see: (a) Huryn, D. N.; Okabe, M. Chem. Rev. 1992, 92, 1745.
4. (b) Borthwick, A. D.; Biggadike, K. Tetrahedron 1992, 48, 571.
5. (c) Agrofolio, L.; Suhas, E.; Farese, A.; Condom, R.; Challand, S. R.; Earl, R. A.; Guedj, R. Tetrahedron 1994, 50, 10611.
6. For synthetic approaches to cyclobutane nucleosides, see: (a) Slusarchyk, W.; Bisacchi, G. S.; Field, A. K.; Hockstein, D. R.; Jacobs, G. A.; McGeever-Rubin, B.; Tino, J. A.; Tuomari, A. V.; Yamanaka, G. A.; Young, M. G.; Zahler, R. J. Med. Chem. 1992, 35, 1799.
7. (b) Ishigami, S.; Togo, H.; Yokoyama, M. J. Chem. Soc. Perkin Trans. I 1994, 2407.
8. (c) Booth, B. L.; Eastwood, P. R. J. Chem. Soc. Perkin Trans. I 1995, 669.
9. (d) Kaiwar, V.; Reese, C. B.; Gray, E. J.; Neidle, S. J. Chem. Soc. Perkin Trans. 1995, 2281.
10. (e) Gharbaoui, T.; Legraverend, M.; Ludwig, O.; Bisagni, E.; Aubertin, A.-M.; Chertanova, L. Tetrahedron 1995, 51, 1641.
11. (f) Mévellec, L.; Huet, F. Tetrahedron 1997, 53, 5797.
12. Most of the reported syntheses of cyclopropyl carbocyclic nucleosides are referred to racemic compounds. For the asymmetric synthesis of this class of nucleosides see, for instance: (a) Zhao, Y.; Yang, T.; Lee, M.; Lee, D.; Newton, M. G.; Chu, C. K. J. Org. Chem. 1995, 60, 5236.
13. (b) Lee, M.; Lee, D.; Zhao, Y.; Newton, M. G.; Chun, M. W.; Chu, C. K. Tetrahedron 1995, 36, 3499.
14. (a) Cyclobut-G 3 has been found to have anti-HIV activity comparable to that of AZT: Norbeck, D. W. Kern, E.; Hayashi, S.; Rosenbrook, W.; Sham, H.; Herrin, T.; Plattner, J. J.; Erickson, J.; Clement, J.; Swanson, R.; Shipkowitz, N.; Hardy, D.; Marsh, K.; Arnett, G.; Shannon, W.; Broder, S.; Mitsuya, H. J. Med. Chem. 1990, 33, 1281.
15. (c) Antitumor activity of racemic 4: Csuk, R.; von Scholz, Y. Tetrahedron 1995, 51, 7193.
16. Ashton, W. T.; Canning Meurer, L.; Cantone, C. L.; Field, A. K.; Hannah, J.; Karkas, J. D.; Liou, R.; Patel, G. F.; Perry, H. C.; Wagner, A. F.; Walton, E.; Tolman, R. L. J. Med. Chem. 1988, 31, 2304.
17. Wang, G.; Middleton, P. J. Tetrahedron Lett. 1996, 37, 2739.
18. Arita M.; Adachi, K.; Ito, Y.; Sawai, H.; Ohno, M. J. Am. Chem. Soc. 1983, 105, 4049.
19. (a) Díaz, M.; Ibarzo, J.; Ortuño, R. M. Tetrahedron: Asymmetry 1994, 5, 37.
20. (b) Díaz, M. Branchadell, V.; Oliva, A. Ortuño, R. M. Tetrahedron 1995, 51, 11841.
21. (a) Shaw, G.; Warrener, R. N. J. Chem. Soc. 1958, 153.
22. (c) Shealy, Y. F.; O'Dell, C. A.; Thorpe, M. C. J. Heterocycl. Chem. 1981, 18, 383.
23. 12. Yields of these reactions are usually in the range 15-45%. See, for instance Ref. 6(b).